Cardiomyocyte remodeling in ischemic heart disease

Dalia Pangonyte1, Elena Stalioraityte, Reda Ziuraitiene

  • 1Institute of Cardiology, Kaunas University of Medicine, Sukileliu 17, Kaunas, Lithuania. dalia.pangonyte@med.kmu.lt

Insights

Cardiomyocyte hypertrophy, an enlargement of heart muscle cells, occurs before the first myocardial infarction in ischemic heart disease (IHD). This cellular change precedes significant heart tissue loss, indicating early cardiac remodeling.

Area of Science:

  • Cardiovascular Pathology
  • Cardiac Histomorphometry
  • Ischemic Heart Disease Research

Background:

  • Ischemic heart disease (IHD) involves chronic ischemia and cardiac tissue loss.
  • Left ventricular cardiomyocyte size and shape changes are key indicators of cardiac response.
  • Understanding these changes is crucial for diagnosing and managing IHD progression.

Purpose of the Study:

  • To detect alterations in left ventricular cardiomyocyte size and shape.
  • To investigate these changes in response to chronic ischemia and myocardial infarction.
  • To determine the timing of these cellular changes within the course of IHD.

Main Methods:

  • Histomorphometric analysis of left ventricular cardiomyocyte dimensions (diameter, length).
  • Assessment of cardiomyocyte cross-sectional area and volume.
  • Comparison between preinfarction IHD, postinfarction IHD, and control groups.

Main Results:

  • Significant cardiomyocyte hypertrophy (32.0% volume increase) was observed in the preinfarction IHD group compared to controls.
  • Preinfarction IHD group showed increased cross-sectional area (17.2%) and length (12.5%).
  • No significant differences in cardiomyocyte parameters were found between preinfarction and postinfarction IHD groups.

Conclusions:

  • Left ventricular cardiomyocyte hypertrophy precedes the first myocardial infarction in IHD.
  • Cardiomyocyte dimensions remain stable post-myocardial infarction until congestive heart failure develops.
  • Early cellular hypertrophy is a hallmark of preinfarction IHD.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...